Pancreatic Cancer Research

ResearcherJuntendo UniversityNo recent work listed

Kazuo Watanabe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1810-5308; OpenAlex author ID A5103047544. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: 2 papers

Papers 3

  1. Fibroblast inhibition by tocilizumab enabled gemcitabine/nab-paclitaxel rechallenge for pancreatic cancer. Co-author DOI 10.1111/cas.15929↗
  2. Clinical course of anorexia-cachexia according to type of first-line chemotherapy for advanced pancreatic cancer Co-author DOI 10.21203/rs.3.rs-3048794/v1↗
  3. The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer. Co-author DOI 10.1002/cam4.2954↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuichi Mitsunaga · 3 shared papers, 2020–2023 · strength 0.43
  2. Mitsuhito Sasaki · 3 shared papers, 2020–2023 · strength 0.43
  3. Masafumi Ikeda · 3 shared papers, 2020–2023 · strength 0.43
  4. Hiroshi Imaoka · 3 shared papers, 2020–2023 · strength 0.43
  5. Atsushi Ochiai · 2 shared papers, 2020–2023 · strength 0.25
  6. Tomoyuki Satake · 1 shared paper, 2023 · strength 0.18
  7. Akihiro Ohba · 1 shared paper, 2023 · strength 0.18
  8. Takuji Okusaka · 1 shared paper, 2023 · strength 0.18
  9. Kazunori Aoki · 1 shared paper, 2023 · strength 0.15
  10. Toshihiro Yamaguchi · 1 shared paper, 2023 · strength 0.15
  11. Hiroyuki Tsunoda · 1 shared paper, 2023 · strength 0.15
  12. Ai Irisawa · 1 shared paper, 2020 · strength 0.10
  13. Motohiro Kojima · 1 shared paper, 2020 · strength 0.10
  14. Hidetaka Suzuki · 1 shared paper, 2020 · strength 0.10
  15. Tetsuo Akimoto · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.